Ask Onix
Migraines: A global health crisis with staggering impacts
One in five women worldwide suffers from migraines, making it the second-leading cause of years lived with disability. Yet research funding remains disproportionately low, and many specialists still dismiss it as a minor ailment.
The personal toll of migraines
For many, migraines are far more than a bad headache. Attacks can include blinding pain, vision distortion, and severe nausea-symptoms that force some to abandon careers and daily routines. One sufferer described how a dull evening headache escalated into unbearable agony, followed by vomiting, a pattern she has endured repeatedly in recent years.
Unlike typical headaches, migraines resist common painkillers and lack a definitive cause. Hormonal fluctuations and abnormal brain activity are suspected triggers, but no sustainable treatment exists.
A silent epidemic with massive costs
From 1990 to 2016, migraines consistently ranked as the second-largest contributor to global disability years. The economic burden is equally severe-UK workers alone take an estimated 25 million sick days annually due to migraines. Despite this, funding for research remains among the lowest for neurological conditions.
In 2017, U.S. migraine research received just $22 million (£17 million), while asthma-affecting half as many people-garnered 13 times more funding. Diabetes, impacting two-thirds as many individuals, received 50 times the investment. Even in Europe, migraines receive the least public funding of any neurological illness.
Gender disparity in diagnosis and research
Women are three times more likely to experience migraines than men, with one in five affected compared to one in 15 men. A 2018 University of Arizona study suggested hormonal differences may play a role. Female rats with higher estrogen levels showed reduced levels of the sodium proton exchanger NHE1, which regulates pain signaling.
"Women may be more susceptible because hormonal fluctuations affect NHE1 expression," said researcher Emily Galloway.
Yet most animal studies on migraines use male subjects, mirroring a broader trend in medical research. This neglect may stem from historical biases-physicians have long dismissed women's pain, linking migraines to hysteria or mental instability.
Historical stigma and modern misunderstandings
Migraines are one of humanity's oldest recorded ailments, documented in ancient Egyptian texts and Hippocratic writings. The term itself derives from the Greek hemicrania, meaning "half skull," referencing the one-sided pain characteristic of attacks.
In the 19th century, doctors attributed migraines to "weak minds" in working-class mothers, while 20th-century neurologist Harold G. Wolff claimed female patients suffered due to their inability to accept traditional gender roles. Such stereotypes persist today, with some thesauruses even listing "migraine" as a synonym for "spouse."
Mental health and migraines: A complex link
Studies show migraines often coincide with psychiatric disorders. Sufferers are 2.5 times more likely to develop generalized anxiety disorder and three times more likely to experience depression. One in six migraine patients has considered suicide, compared to one in 10 in the general population.
"The overlap with other diseases is high, but causation remains unclear," said Messoud Ashina, director of the Danish Headache Centre's Human Migraine Research Unit.
Experts suggest the unpredictability of attacks fuels anxiety, while chronic pain can deepen feelings of helplessness and depression.
Breakthroughs and barriers in treatment
Despite the disorder's prevalence, many neurologists still don't consider migraines "real neurology." This bias has hindered research and funding, particularly for a condition predominantly affecting women.
New treatments offer hope. Erenumab, a monthly injection, blocks a brain receptor that triggers migraines. Approved by the FDA in 2018, it's the first drug designed specifically for migraines, unlike repurposed medications like beta blockers, which can cause severe side effects.
Other innovations include handheld devices that use magnetic pulses to reduce neural hyperexcitability. For one patient, these advances can't come soon enough-after six migraine-free months, a recent attack sent her to the hospital with a suspected heart issue, a false alarm but a stark reminder of the risks of current treatments.
The path forward
With millions affected globally, experts argue migraines deserve urgent attention. As one neurologist noted, "Headache is the most common symptom in neurology clinics, yet it's the least taught to medical residents. It's like training electricians but not telling them about light bulbs."
Greater awareness, equitable research funding, and gender-sensitive medical training could help dismantle the stigma and improve care for migraine sufferers worldwide.
